New evidence on the impact of cervical cancer screening and treatment using HPV DNA tests, visual inspection or cytology (Pap)
ثبت نشده
چکیده
A study published by Sankaranarayanan et al. in the April 2, 2009 edition of the New England Journal of Medicine added to the growing evidence that a significant impact on cancer mortality can be achieved by offering women even a single opportunity for cervical cancer screening using an HPV DNA test followed by treatment as indicated. In contrast to previous findings, the new study from India found no significant reductions in cancer cases among women offered screening/treatment using cytology (Pap screening) or visual inspection with acetic acid (VIA). It is not unusual for studies to show differing results, and it is important to consider the entire body of evidence before significantly revising policy. This Alliance for Cervical Cancer Prevention (ACCP) fact sheet seeks to put the new findings into context and respond to questions arising in light of this new information, especially questions related to continuing investment in VIA-based programs. ACCP recommends that countries, areas, or institutions...consider introducing or expanding VIA plus cryotherapy programs...until appropriate and affordable HPV DNA tests become available.
منابع مشابه
Pnm-17: Cost Effectiveness of Human Papillomavirus Testing in Cervical Cancer Diagnosis
Background: Epidemiological studies are shown robust association between human papillomavirus (HPV) and cervical cancer. From 1990 HPV was known as a necessary but insufficient cause of cervical invasive cancer. The purpose of this study was to evaluate the cost effectiveness of HPV test in cervical cancer screening. Materials and Methods: This is a systematic review article; the newest scienti...
متن کاملEvidence-based screening, early diagnosis and treatment strategy of cervical cancer for national policy in low- resource countries: example of India.
Cervical cancer remains the most frequent cancer in women from the developing world. More than 88% of deaths occur in low-income countries, and it is predicted to climb to 91.5% by 2030. Although Pap-based screening programmes have shown to be effective in reducing the disease burden in high-resource countries, implementation and sustention of cytology-based programmes is quite challenging in l...
متن کاملInternational Breast Cancer Screening Network (IBSN)
BACKGROUND: Cytology-based screening using the Pap smear has been the main screening method used for the secondary prevention of cervical cancer worldwide. Countries able to implement broad screening coverage at frequent intervals have had success in reducing cervical cancer mortality. In many low-income countries, however, traditional cytology screening has proved difficult to sustain because ...
متن کاملChapter 13: Primary screening of cervical cancer with human papillomavirus tests.
Despite its history of success in cancer screening, Pap cytology has important limitations, particularly its high false-negative rate, which carries important public health implications. Since the mid-1990s, there has been substantial interest in the use of human papillomavirus (HPV) DNA testing in cervical cancer screening under the premise that the testing of cervical cells for the causative ...
متن کاملAcceptability of Self-sampling HPV Testing among Thai Women Attending Cervical Cancer Screening
Cervical cancer is the second most common female cancer in Thailand and worldwide (IARC, 2005; Ferlay et al., 2010). Persistence high risk HPV infection is known as a leading cause of cervical cancer (Schiffman and Kjaer, 2003; IARC, 2005). Most of the cervical cancer cases developed in the developing countries. Despite of the wide spreading of the disease, cervical cancer is one of the prevent...
متن کامل